Veeva Systems Inc.

- There is no mention of any current or planned new fundraising through debt or equity in the provided transcript from Veeva Systems' Q4 2026 earnings call. - The discussion primarily focuses on product development, customer adoption, AI integration, and financial performance. - No executives reference issuing new debt, equity offerings, or capital raises during the call. - The focus is on executing existing strategies, product rollouts, and customer commitments rather than raising new capital.

- The company is making a "big push" on tech enabling their services, expecting benefits to materialize in the next 1-2 years, particularly leveraging AI for faster and cost-effective system migrations (Page 16). - There is ongoing investment in product excellence and value creation rather than pricing or margin structure adjustments, with no material impact expected for FY '27 but potentially in future years (Page 15). - Continued growth and hiring to support strong demand in professional services, including business consulting, R&D services, CRM migration activities, and digital events (Page 9). - Expansion of AI agents across product areas in FY '27 with plans for rollout and refinement, indicating ongoing R&D and technology investments (Page 14). - Investment into Vault CRM to convert top 20 customers and enhance product stability, supporting growth and migration efforts (Pages 12-15).

- Fiscal '27 total revenue growth guide is 13%, reflecting healthy but more cautious growth compared to fiscal '26's 16% actual outperformance. - Growth in subscription revenue expected at 13% for fiscal '27, with a mix shift towards newer R&D products (RTSM, EDC, safety, LIMS) which are large and growing fast but still scaling. - Commercial segment shows some slowing growth but remains healthy; Crossix growth expected to moderate as it laps harder compares. - Vault CRM customer base grows strongly, with ~140 customers live and opportunities for cross-sell to other products (Network, OpenData, Service Center, Campaign Manager). - AI-driven product offerings are early-stage; expected to grow and add value over coming years but are not yet major financial contributors. - Professional services outperformed and are expected to grow further, supporting system migrations and implementations.

- FY ’27 revenue growth guidance is 13%, reflecting strong but more normalized growth compared to FY ’26's 16% actual (5 points beat over initial 11% guide). - AI-related products (agentic AI offerings) are early-stage; not expected to materially impact FY ’27 financials but anticipated to contribute in later years. - Continued healthy growth expected from R&D products like RTSM and EDC, with shifts from mature products to higher-growth newer offerings. - Operating margins remain strong with current non-GAAP operating income at $366M (Q4 FY26) and $1.434B (FY26), with margin profile stable. - CRM business projected to be stable with incremental growth from add-on products but decreasing as a percent of total revenue by 2030 (~10% from 20% today). - Services revenue and CRM migration projects expected to ramp in FY ’27, contributing moderately to revenue and margins. - Management emphasizes cautious but optimistic guidance, focusing on product excellence, customer success, and scaling new growth areas.

- The company refers to "billings" as a key indicator of business momentum rather than providing quarterly guidance. - They continue to provide annual normalized billings guidance, updated quarterly. - Seasonality in billings is expected to be directionally similar to the prior year. - Top 20 projects, including those for Vault CRM, are at various stages—wrapping up, underway, or kicking off throughout the fiscal year. - Services revenue is expected to ramp up in fiscal ’27 tied to these go-live projects. - The transition away from Salesforce and migration to Vault CRM is progressing steadily with nearly 140 customers live. - There is strong execution and demand in both commercial and R&D services segments. - The company is on track to achieve ~14 out of 20 top pharma commitments for Vault CRM by mid-calendar ’26, indicating a robust demand pipeline.